Ronit Satchi-Fainaro

Ronit Satchi-Fainaro

Tel Aviv University

H-index: 56

Asia-Israel

About Ronit Satchi-Fainaro

Ronit Satchi-Fainaro, With an exceptional h-index of 56 and a recent h-index of 36 (since 2020), a distinguished researcher at Tel Aviv University, specializes in the field of Cancer, Angiogenesis, Nanomedicine, Theranostics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Beyond IL-2: The promise of anti PD-1-attenuated IL-2 fusion protein in cancer immunotherapy

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Chemiluminescent probes for diagnostics and in vivo imaging

Unlocking solid tumors to nano-immunotherapy

A nano sized system for the treatment of gastrointestinal cancers

Combining TIGIT blockage with MDSC inhibition hinders breast cancer bone metastasis by activating anti-tumor immunity

3D-bioprinted cancer models for target discovery, drug development, and personalized therapy

A PD1-antibody-attenuated IL-2 fusion protein activates immune cells leading to the inhibition of tumor growth in ex vivo human 3D tumor models

Ronit Satchi-Fainaro Information

University

Position

Professor

Citations(all)

9878

Citations(since 2020)

4812

Cited By

7256

hIndex(all)

56

hIndex(since 2020)

36

i10Index(all)

130

i10Index(since 2020)

113

Email

University Profile Page

Tel Aviv University

Google Scholar

View Google Scholar Profile

Ronit Satchi-Fainaro Skills & Research Interests

Cancer

Angiogenesis

Nanomedicine

Theranostics

Top articles of Ronit Satchi-Fainaro

Title

Journal

Author(s)

Publication Date

Beyond IL-2: The promise of anti PD-1-attenuated IL-2 fusion protein in cancer immunotherapy

Cancer Research

Sarah Amar

Yulia Liubomirski

Eilam Yeini

Michael Monsonego

Tomer Weiss

...

2024/3/22

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy

Advanced Functional Materials

Carina Peres

Ana I Matos

Bárbara Carreira

Liane IF Moura

Ron Kleiner

...

2024/4/1

Chemiluminescent probes for diagnostics and in vivo imaging

2024/3/19

Unlocking solid tumors to nano-immunotherapy

Cancer Research

Barbara Carreira

Rita C Acúrcio

Ana I Matos

Liane M Moura

Ana C Santos

...

2024/3/22

A nano sized system for the treatment of gastrointestinal cancers

Cancer Research

Daniella Vaskovich

Rita Acúrcio

Ron Kleiner

Barbara Carreira

Ana Matos

...

2024/3/22

Combining TIGIT blockage with MDSC inhibition hinders breast cancer bone metastasis by activating anti-tumor immunity

Cancer Discovery

Lea Monteran

Nour Ershaid

Ye'ela Scharff

Yazeed Zoabi

Tamer Sanalla

...

2024/3/1

3D-bioprinted cancer models for target discovery, drug development, and personalized therapy

Cancer Research

Ronit Satchi-Fainaro

Anne Krinsky

Anshika Katyal

Opal Avramoff

Eilam Yeini

...

2024/3/22

A PD1-antibody-attenuated IL-2 fusion protein activates immune cells leading to the inhibition of tumor growth in ex vivo human 3D tumor models

Cancer Research

Ronit Satchi-Fainaro

Opal Avramoff

Anshika Katyal

Eilam Yeini

Anne Krinsky

...

2024/3/22

Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker

Journal of Controlled Release

Yulia Liubomirski

Galia Tiram

Anna Scomparin

Samer Gnaim

Sayantan Das

...

2024/3/1

A dendritic cell targeted nanosystem to overcome immune suppression and enhance the efficacy of the standard of care for pancreatic cancer

Cancer Research

Ron Kleiner

Daniella Vaskovich-Koubi

Rita Acúrcio

Barbara Carreira

Helena Florindo

...

2024/3/22

P-selectin as an emerging target for the treatment of primary and secondary brain tumors

Cancer Research

Eilam Yeini

Ronnie Frommer-Shapira

Alisa Talianski

Paula Ofek

Sabina Pozzi

...

2024/3/22

Elucidating the role of P-selectin/P-selectin ligand-1 axis in lung cancer brain metastasis

Cancer Research

Koren Salomon

Eilam Yeini

Neta Frommer

Irisi Kamer

Jair Bar

...

2024/3/22

Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma

International Journal of Cancer

Paula Ofek

Eilam Yeini

Gali Arad

Artem Danilevsky

Sabina Pozzi

...

2023/5/4

interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptors

Asaf Madi

Ron Sheinin

Koren Salomon

Eilam Yeini

Shai Dulberg

...

2023/10/31

Translational nanotechnology-based cancer vaccine to re-educate host immune response against metastatic cancers

Cancer Research

Barbara Carreira

Rita A Acúrcio

Sabina Pozzi

Ron Kleiner

Liane I Moura

...

2023/4/4

Methods of treating glioblastoma

2023/2/16

Modulating the brain immune system to fight cancer in 3 dimensions

Cancer Research

Eilam Yeini

Daniella Vaskovich-Koubi

Ron Kleiner

Helena F Florindo

Ronit Satchi-Fainaro

2023/4/4

Polymeric conjugates and uses thereof

2023/9/7

Inactivation of p53 drives breast cancer brain metastasis by altering fatty acid metabolism

bioRxiv

Kathrin Laue

Sabina Pozzi

Yael Cohen-Sharir

Tom Winkler

Yonatan Eliezer

...

2023

Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors

Advanced Science

Ana I Matos

Carina Peres

Barbara Carreira

Liane IF Moura

Rita C Acúrcio

...

2023/9

See List of Professors in Ronit Satchi-Fainaro University(Tel Aviv University)

Co-Authors

H-index: 65
Doron Shabat

Doron Shabat

Tel Aviv University

H-index: 60
Yuval Shaked

Yuval Shaked

Technion - Israel Institute of Technology

H-index: 24
Anna Scomparin

Anna Scomparin

Università degli Studi di Torino

H-index: 16
Shiran Ferber

Shiran Ferber

Massachusetts Institute of Technology

H-index: 12
Dina Polyak

Dina Polyak

Stanford University

academic-engine